European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop: Integrating pharmacogenomics early into drug development: pharmacokinetics as a working example
Date:
20/12/2008
Location:
European Medicines Agency, London, UK
-
List item
Agenda - European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop: Integrating pharmacogenomics early into drug development: Pharmacokinetics as a working example (PDF/46.7 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop: Integrating pharmacogenomics early into drug development: Pharmacokinetics as a working example (PDF/52.32 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Applications of pharmacogenomics in pharmacokinetics at the European Medicines Agency: Experience and expectations (PDF/473.62 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Pharmacogenomics in early drug development: Industry's view (PDF/13.46 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Applications of pharmacogenomics in pharmacokinetics at the Pharmaceuticals and Medical Devices Agency: Experience and expectations (PDF/2.46 MB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Application of pharmacogenomics in pharmacokinetics at the Food and Drug Administration: Experience and expectations (PDF/77.79 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Gaining consensus on emerging science: The Absorption, Distribution, Metabolism and Excretion Panel as an exemplar (PDF/1.31 MB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Pharmacokinetics and pharmacogenomics: Building blocks for the cases in session 3 (PDF/105.13 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Case 1: Pharmacogenomic design in phase I based on in-vitro data (PDF/44.26 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Case 3: Integrating pharmacogenomics early into drug development: Pharmacokinetics as a working example (PDF/788.85 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Case 4: Integrating pharmacogenomics early into drug development: Pharmacokinetics as a working example (PDF/86.08 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Core data set: CYP2D6 metabolism (PDF/25.79 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Phase 2a trial design is being planned: How does pharmacokinetic variation observed in phase I affect trial design? (PDF/8.39 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Pharmacogenomic data submission to biomarker scientific advice: Task: What does the team do next? (PDF/565.61 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Presentation - Case 4: Goal: What does team plan for phase 2b trial? (PDF/51.51 KB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Application of PGx in PK in medical practise: How does PGx inform decisions? - Munir Pirmohamed (PDF/1.79 MB)
First published: 19/12/2008
Last updated: 19/12/2008 -
List item
Report on the EMEA/EFPIA Pharmacogenetics Workshop on Integrating Pharmacogenetics Early into Drug Development: PK as a working example (PDF/65.32 KB)
First published: 29/05/2009
Last updated: 29/05/2009
EMEA/151623/2009